1. Home
  2. PTIX vs ULY Comparison

PTIX vs ULY Comparison

Compare PTIX & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • ULY
  • Stock Information
  • Founded
  • PTIX 1994
  • ULY 2013
  • Country
  • PTIX United States
  • ULY United States
  • Employees
  • PTIX N/A
  • ULY N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • PTIX Health Care
  • ULY
  • Exchange
  • PTIX Nasdaq
  • ULY Nasdaq
  • Market Cap
  • PTIX 6.3M
  • ULY 5.8M
  • IPO Year
  • PTIX 2016
  • ULY N/A
  • Fundamental
  • Price
  • PTIX $2.76
  • ULY $2.80
  • Analyst Decision
  • PTIX
  • ULY Strong Buy
  • Analyst Count
  • PTIX 0
  • ULY 2
  • Target Price
  • PTIX N/A
  • ULY $11.50
  • AVG Volume (30 Days)
  • PTIX 73.5K
  • ULY 990.9K
  • Earning Date
  • PTIX 11-13-2025
  • ULY 11-12-2025
  • Dividend Yield
  • PTIX N/A
  • ULY N/A
  • EPS Growth
  • PTIX N/A
  • ULY N/A
  • EPS
  • PTIX N/A
  • ULY N/A
  • Revenue
  • PTIX N/A
  • ULY $131,235,000.00
  • Revenue This Year
  • PTIX N/A
  • ULY N/A
  • Revenue Next Year
  • PTIX N/A
  • ULY $20.23
  • P/E Ratio
  • PTIX N/A
  • ULY N/A
  • Revenue Growth
  • PTIX N/A
  • ULY N/A
  • 52 Week Low
  • PTIX $2.25
  • ULY $2.63
  • 52 Week High
  • PTIX $15.26
  • ULY $17.99
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 35.75
  • ULY 37.14
  • Support Level
  • PTIX $2.85
  • ULY $2.63
  • Resistance Level
  • PTIX $3.19
  • ULY $3.07
  • Average True Range (ATR)
  • PTIX 0.23
  • ULY 0.27
  • MACD
  • PTIX -0.04
  • ULY 0.02
  • Stochastic Oscillator
  • PTIX 5.61
  • ULY 17.28

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: